Live Markets
Wednesday, July 29, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Financials

Drugs Made In America Acquisition Corp. (DMAA)

NGM · Shell Companies

$10.71+0.01 (+0.09%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$260.0M
P/E (TTM)
53.55
EPS
$0.20
Div Yield
52W Range
$10.22–$10.72
Beta

Company overview

Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combinations with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in New York, New York.

Peers in Shell Companies

All in industry →

Recent press releases

Drugs Made In America Acquisition Corp. has not issued a press release in this window.

SEC filings

All filings →

Drugs Made In America Acquisition Corp. has not filed an SEC document in this window.

Drugs Made In America Acquisition Corp. has no reported insider trades in the last 90 days.

Institutional holders

All holders →

No 13F holdings have been reported for Drugs Made In America Acquisition Corp. in this window.

People at Drugs Made In America Acquisition Corp.

All people →

Quarterly financials

Full financials →

No quarterly financials have been ingested for Drugs Made In America Acquisition Corp..